Na gode da ziyartar yanayi.com. Sigar mai binciken da kuke amfani da ita yana iyakance tallafin CSS. Don mafi kyawun gogewa, muna ba da shawarar cewa kayi amfani da sabuntawa (ko kashe yanayin dacewa a cikin Internet Explorer). A halin yanzu, don tabbatar da ci gaba da tallafi, za mu sanya shafin ba tare da salon da javascript ba.
Ana amfani da peptiges da sunadarai da yawa don amfani da cututtuka daban-daban, amma yawanci dole ne a allura kuma tasirinsu sun gajarta. Waɗannan kasawar 'yan ƙasa za a iya kawar da su tare da taimakon injiniyan kwayoyin, amma wannan aiki ne mai wahala. Hanyoyin injiniya na kwayoyin, wanda aka yi amfani da shi zuwa insulin kuma yanzu anyi nasarar amfani da biopharmacid da yawa, suna buƙatar lalata peptides da sunadarai daga kitse acid. Daidai halaye da wurin da mai kitse mai akasari zai iya samar da hanyoyin musanya daban-daban. Bugu da kari, wannan fasaha na iya samar da dogon rayuwa rabin lokaci bayan aikin kwantar da kwayoyi na peptide, na iya canza rarraba peptides, kuma yana iya samun damar da nama manufa. Tare da amincin aminci acid da kyau-da aka ayyana kaddarorin sunadarai, wannan fasaha tana samar da kusancin abin da ya dace da binciken magungunan peptide da furotin magunguna.
Duk farashin ne net. Za a kara VAT daga baya a wurin biya. Za'a yi lissafin haraji a wurin biya.
Mutthamer, M, King, GF, Adams, Dj & Alweood, Pf Trends a cikin binciken kwayoyi ƙwayoyin cuta. Mutthamer, M, King, GF, Adams, Dj & Alweood, Pf Trends a cikin binciken kwayoyi ƙwayoyin cuta.Mutthamer, M, King, GF, Adams, Dj da Alevud, Pf Trends a cikin binciken kwayoyi na pf. MuttHaler, M, Sarki, GF, Adams, Dj & Sewood, PF 多肽药物发现 的 的. Mutthamer, M, Sarki, Adams, Adams, Dj & Alwayew, PFMutthamer, M, King, GF, Adams, Dj da Alevud, Pf Trends a cikin binciken kwayoyi na pf.Kamfanin bude magungunan magunguna. 20, 309-325 (2021). Wannan review ya mai da hankali ne akan bangarorin na yanzu da na gaba na binciken kwayoyi na peptide.
Müller, TD, Blüwarp, M., Tschöp, MH & Dimhici, binciken magungunan ƙwayoyi: ci gaba da kalubale. Müller, TD, Blüwarp, M., Tschöp, MH & Dimhici, binciken magungunan ƙwayoyi: ci gaba da kalubale.Müller, TD, Blucher, M., sara, MH da kuma binciken magunguna, ci gaba da kalubale. Müller, TD, Blüwar, M., TSCHöp, MH & DimewaCi, RD 抗肥胖药物发现: 进展和挑战. Müller, TD, Blücp, MH & Dimawarici, RDMüller, TD, Blucher, M., sara, MH da kuma binciken magunguna, ci gaba da kalubale.Kamfanin bude magungunan magunguna. 21, 201-223 (2022). Wannan bita yana ba da haske game da matsalolin kiba, musamman sabon dabaru dangane da peptides.
Strohl, sunadar sunadaran da aka yi wa ambaliyar rabin tunanin ilmin halitta a matsayin mafi kyawun dabarar biolologid. Biopharmamactics 29, 215-239 (2015).
Evans, M. et al. Yin bibence da kuma dagewa da magunguna na rigakafi da kuma sakamako na asibiti da tattalin arziki a cikin marasa lafiya da nau'in ciwon sukari na 2: sake duba wallafe-wallafen. ciwon sukari. metabolism. 24, 377-390 (2022).
Polononsky, Wh, Fisher, L., Hessler, Brushh, Brand, Ra'ayoyi masu haƙuri na JH & Magoya bayan Magunguna na Sati na Sati. Polononsky, Wh, Fisher, L., Hessler, Brushh, Brand, Ra'ayoyi masu haƙuri na JH & Magoya bayan Magunguna na Sati na Sati.Polononsky Wh, Fisher L., Hessler D., Brune D., kuma mafi kyawun JH mai haƙuri game da magunguna sau ɗaya. Polononsky, Wh, Fisher, L., Hessler, D. & Brush, D. & mafi kyau, Jh 的 的 的 的 一 的 一的. Polononsky, Wh, Fisher, L., Hessler, D., Brushh, D. & mafi kyau, JhPolonsky Wh, Fisher L., Hessler D., Brune D., kuma mafi kyawun tsinkayen Magicationsari na magunguna sau ɗaya-mako-mako.ciwon sukari. metabolism. 13, 144-149 (2011).
Hashimoto, M., TAKDAO, K., Kiso, Y. & Mutushi, S. Synthesis na Palmitoyl na Insulin da ayyukan nazarin halittu. Hashimoto, M., TAKDAO, K., Kiso, Y. & Mutushi, S. Synthesis na Palmitoyl na Insulin da ayyukan nazarin halittu.Hashimoto M., Takada K., Kiso Y.sanish S. synthesis na Palmitoyl nas na insulin da aikin halittunsu. Hashimoto, M., TAKDA, K., Kiso, Y. & Muranhi, S. 胰岛素棕榈酰衍生物 的 合成及其生物活性. Hashimoto, M., TAKDAO, K., Kiso, Y. & Mutushi, S. Synthesishi, S. Synthesishi, S. Synthesishi, S. kira da ayyukan nazarin insulin palmmitoyl.Hashimoto M., TAKA K., KOSO Y. da Muranhi S. Synthesis da aikin nazarin Insulin Palmmitoys.Magunguna na reservoir 6, 171-176 (1989).
Kurtzhals, P. et al. Albnoye ga mai-acid in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in in insulin: dangantaka game da huldar ligand-furotin da daidaitaccen lokaci a cikin VIVO. biochem. J. 312, 725-731 (1995). Wannan aikin shine farkon wanda zai nuna karuwar rabin rayuwa saboda tsananin album a peptivesive daga mai acid.
Mejuch, T. & Waldmann, H. Synthesis na Finion sunadarai. Mejuch, T. & Waldmann, H. Synthesis na Finion sunadarai.Meyukh, T. da Waldmann, H. kira na sunadarai sunadarai. Mejuch, T. & Waldmann, H. 脂化蛋白质 的. Mejuch, t. & Waldmann, H.Meyukh, T. da Waldmann, H. kira na sunadarai sunadarai.Bioconjugate. Sunadarai. 27, 1771-1783 (2016).
Chen, B., Rana, Y., Niu, J., da Wu, X., tsari, tsari, da kuma damar warkewa. Chen, B., Rana, Y., Niu, J., da Wu, X., tsari, tsari, da kuma damar warkewa.Chen B., Sun Y. Chen, B., Rana, Y., Niu, J., Jaruguguasalilli, GK & Wu, x. 细胞信号和疾病, 调节和治疗机会. Chen, B., Rana, Y., Niu, J., da Wu, X. Daraja da dama na sel.Chen B., Sun Y.cytocemistry. Halitse 25, 817-831 (2018).
Richter, WF, Bhansali, SG & Morris, ni da ƙimar ƙayyade na ƙirar biotrapeustics na ɗaukar sc. Richter, WF, Bhansali, SG & Morris, ni da ƙimar ƙayyade na ƙirar biotrapeustics na ɗaukar sc.Richter, VF, Bhansali, SG da Morris, ME ME MEATSAYIN WA YI AMFANI DA ITA NA TARIHI NA KUDI. Richter, WF, Bhansali, SG & Morris, ni SC 的 的. Richter, WF, Bhansali, SG & Morris, ni SC Richter, WF, Bhansali, SG & Morris, ni SC МЕхаАНИсти Аботерапевтиховти Аботерапевтихотов Препаратов препаратов Richter, WF, Bhansali, SG & Morris, mani masu yanke shawara na sc inji na tunawa da magungunan biotherapeus bayan gudanarwa.AAPS J. 14, 559-570 (2012).
Gradel, Akj et al. Abubuwan da ke shafar hpautiptionarfin insulin na subcutous: Abubuwan da ke cikin bambanta. J. Ciwo Res. 2018, 1205121 (2018).
Hildebrandt, P., Sejresen, P., Birch, K. & Sattsoft, K. & Sattsoft, K. & Sestoft, K. & Sestoft, K. & Sestoft, K. & Sestoft, K. & Sestoft, K. & Sestoft, K. & Sestoft, K. & Sestoft, L. Hildebrandt, P., Sejresen, P., Birch, K. & Sattsoft, K. & Sattsoft, K. & Sestoft, K. & Sestoft, K. & Sestoft, K. & Sestoft, K. & Sestoft, K. & Sestoft, K. & Sestoft, K. & Sestoft, L. Hildebrandt, P., Sejresen, P., Nixsen, Sl, Birch, K. & Sestoft, K. & Sestoftория изоду опияедкой изоду у пациентов сдобБыем. Hildebrandt, P., Sejresen, SEJESEN, SL, Birch, K. & Sattch, K. & Sattsoft, L. & Sestoft, K. & Sestoft, K. & Sestoft, K. & Sestoft, K. & Sestoft, L. & Sestoft, L. & Sestoft, L. & Sestoft, L. & Sestoft, L. & Sestoft, K. & Sestoft, L. & Sestoft, L. & Sestoft, K. & Sestoft, L. & Sestoft, L. & Sestoft, L. & Sestoft, K. & Sestoft, L. Hildebrandt, P., Sejresen, P., Nehsen, Sl, Birch, K. & Sestoft, L. 扩散和聚合决定了糖尿病患者皮下, 的 吸收. Hildebrandt, P., Sejresen, P., Nehsen, Sl, Birch, K. & Sestoft, L. Hildebandt, P., Sejresen, SEJESEN, SL, Birch, K. & Sestoftоредузй иньор Иацьов диабоМ. Hildebrandt, P., Sejresen, P., Nehsen, Sl, Birch, K. & Sestoft, L. Yatsiya da Taro ya ƙayyade insulin insulin a cikin masu cutar sashe a cikin masu cutar subanic.bincika. J. Klin. dakin gwaje-gwaje. saka jari. 45, 685-690 (1985).
Moseknde, E., Jensen, KS, Bakinder, C., Prinder, S. & Thorsteinsson, B. Santa Fe Kayatarwar insulin ininul. Moseknde, E., Jensen, KS, Bakinder, C., Prinder, S. & Thorsteinsson, B. Santa Fe Kayatarwar insulin ininul.Moseken E, Jensen KS, Bindinder S, Prinder S, Prinder S, da Thorstoreinsson B. Sammalwararren kashin insulin insulin ininulous. Missutde, E., Jensen, KS, Bakinder, C., Prinder, S. & Thorsteinsson, B. 模拟皮下er 的 的 模拟皮 的. Meskilde, e., Jensen, KS, Bakin,, C., Prinder, S. & Thorsteinsson, B.Moseknde e, Jensen KS, Bindinder S, Prinder S, Prinding S, da Thorstateinsson B. Sammalwars na shan shayewar insulin.J. Pharmacakingics. biopharmacy. 17, 67-87 (1989).
Kunya, M.., Mahadi, F., Chade, AR & Bidwell, mai tsauri na samar da magunguna na rascymer elastin-kamar pollypeptide. Kunya, M.., Mahadi, F., Chade, AR & Bidwell, mai tsauri na samar da magunguna na rascymer elastin-kamar pollypeptide. Kunve, M.. Аиополименолиноподиноподипогогогдепа доственогргре средства. Kunya, M.., Mahadi, F., Chade, AR & BIDWELL, AR III Murfin bioplymicicer-kamar polypeptide na miyagun ƙwayoyi. Kunve, M.., Mahadi, F., Chade, Ar & Bidwell, Gl iii 分子大小调节药物递送生物聚合物弹性蛋白样多肽 的, 生物分布和肾脏沉积. Kuna, M.., Mahadi, F., Chade, Ar & Bidwell, Gil & Bidwell, Gil Iii MoleculeKuna, M.., Mahadi, F., Chadi, Ar da Bidwell, Gl iii. Pharmacakugectics, masu tsini da ajiya da ajiya na bioplymericel na zamani kamar polypeptides modulate girman kwayoyin.Rahoton Kimiyya 8, 7923 (2018).
Harris, JM, Martin, Ne & Modi, M. Tsarin labari: Tsarin sabon labari don gyara magunguna pharmacakiyanci. Harris, JM, Martin, Ne & Modi, M. Tsarin labari: Tsarin sabon labari don gyara magunguna pharmacakiyanci. Harris, JM, Martin, Ne & Barcelona Harris, JM, Martin, Ne & Modi, M. Tsarin labari: Tsarin sabon labari don gyara magunguna pharmacakiyanci. Harris, JM, Martin, Ne & Modi, M. 聚乙二醇化: 种改变药代动力学 的 新方法. Harris, JM, Martin, Ne & Modi, M. 聚乙二感化: sabon hanyar canza magani. Harris, JM, Martin, Ne & Barcelona, ​​May Harris, JM, Martin, Ne & Modi, M. Pecybation: Sabon hanyar da za a iya musayar magunguna.asibiti. Pharmacakaki. 40, 539-551 (2001).
Elmerer, M. et al. A kowane bangare na Albani a cikin kwarangwal din dan adam da kasusuwa mai kauri ta hanyar bude kwali. Ee. J. Likita. endcrine. metabolism. 278, E352-E356 (2000).
Nelson, J. et al. Dogon rabin albums na albums a cikin mutane yana buƙatar m C-Tert. sadarwa. ilmin halitta. 3, 181 (2020).
Chowdhury, K. et al. Kungiyar FC (FCRN) don Igg hade da hadaddun tarihin tarihin da ke da albashin albumin da tsayin daka. J. Exp. magani. 197, 315-322 (2003).
Ober, RJ, Martinez, C., Zhou, J. & Ward, es Excoytosis na IGG ya yi sulhu da matakin karar. Ober, RJ, Martinez, C., Zhou, J. & Ward, es Excoytosis na IGG ya yi sulhu da matakin karar. Ober, RJ, Martinez, C., Zhou, J. & Ward, Опоредоватозте од, опоредоватоз Ober, RJ, Martinez, C., Zhou, J. & Ward recessosis kiran igg exocytosis: bincike na guda ɗaya. Ober, RJ, Martinez, C., Zhou, J. & Ward, 受体介导 的 的 的. Oob, RJ, Martinez, C., Zhou, J. & Ward, es Ober, RJ, Martinez, C., Zhou, J. & Ward, На esовнето Ober, RJ, Martinez, C., Zhou, J. & Ward, or Ward mai karfin gaske.tsari. Kungiyar Kwalejin Kimiyya ta kasa. Kimiyya. US 101, 11076 (2004).
Shi, Xm & Carter, Tsarin dc atomic da Chemistry na ɗan adam album album. Shi, Xm & Carter, Tsarin dc atomic da Chemistry na ɗan adam album album.A, xm da carter, tsarin dc atomic da ilmin sunadarai na ɗan adam. Shi, xm & Carter, DC 的 的 的. Shi, XM & Carter, DC.A, xm da carter, tsarin dc atomic da ilmin sunadarai na ɗan adam.Yanayi 358, 209-215 (1992).
Curry, S., tubelkow, H., bulo, P. & Franks, N. Crystal Tsarin Albani Adama da kitse mai rikitarwa. Curry, S., tubelkow, H., bulo, P. & Franks, N. Crystal Tsarin Albani Adama da kitse mai rikitarwa.Curry S., tubelkow H., bulel P. da Fricks N. Tsarin kris na ɗan adam mai hade da kitse mai kitse yana nuna rarraba kayan maye. Curry, S., bulo, P. & Franks, N. 的 的 的 的 的 不对称分布 的 不对称分布 的 的 的 不对称分布. Curry, S., tubelkow, H., bulo, P. & Franks, N. The Crystal Tsarin dan Adam Farin dan adam Farin dan Adam da KitseCurry S., tubelkow H., bulo P. da Fricks N. Tsarin kris na dan Adam na ɗan adam mai rikitarwa tare da kitse na kitse yana nuna rarraba kayan masarufi.Nat. Tsarin. Biology 5, 827-835 (1998). Wannan takarda tana gabatar da tushen tsarin da ke tattare da kitse na kitse zuwa serum album.
Irby, D., du, du, C. & Li, F. Lipid-miyagun ƙwayoyi na haɓaka isar da miyagun ƙwayoyi. Irby, D., du, du, C. & Li, F. Lipid-miyagun ƙwayoyi na haɓaka isar da miyagun ƙwayoyi.Irby, D., DU, DU, DU, K. da Li, F. Lipid-miyagun ƙwayoyi sun mamaye isar da magunguna. Irby, D., DU, DU, C. & Li, F. Lipid-miyagun ƙwayoyi na haɓaka isar da magunguna. Irby, D., DU, DU, C. & Li, F. Lipid-miyagun ƙwayoyi na haɓaka isar da magunguna.Irby, D., du, du, du, K. da Li, F. Lipid-miyagun ƙwayoyi a inganta isar da magunguna.Biochemistry 14, 1325-1338 (2017).
Torchilin vp ci gaba a cikin filin liposomes a matsayin masu ɗaukar magunguna. Kamfanin bude magungunan magunguna. 4, 145-160 (2005).
Bhat, M., Jatyan, R., Mittal, A., Mahato, Ri & Chitkara, D. Dama da kalubalanci na kitse na Kawance. Bhat, M., Jatyan, R., Mittal, A., Mahato, Ri & Chitkara, D. Dama da kalubalanci na kitse na Kawance.Bhat, M., Jatyan, R., Mittal, A., Mahato, Ri da kalubale, Dama da kalubalanci mai kitse na warkewa. Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. 脂肪酸共轭疗法 的 机遇和挑战. Bhat, M., Jatyan, R., Mittal, A., Mahato, RI & Chitkara, D. Fatety 的 的 机遇和 qalubalam 的 机遇和 qalubalen 的共续电影 的共续电影机遇和机遇和机遇和机遇和机遇和机遇和Bhat M., Jatyan R., Mittal A., Mahato RI da Chitkara D. Tabbas damar da kalubalanci na kitse na kitse.Sunadarai. kimiyyar kimiyyar kimiyyar 236, 105053 (2021).
Smith, R. & Tanford, C. Hydrophobicity of Dogon Sarkar Nathkel Carboxylic acid, kamar yadda aka auna tsakanin Heptane da mafita. Smith, R. & Tanford, C. Hydrophobicity of Dogon Sarkar Nathkel Carboxylic acid, kamar yadda aka auna tsakanin Heptane da mafita.Smith, R. da Tanford, K. Hydrophobicity of Dogon-Al-AlkylcarinBoxylic acid Smith, R. & Tanford, C. 长链正烷基羧酸 的 疏水性, 的 的 分布来测量. Smith, R. & Tanford, C. Alkrophacoxity of 长链正 alkyliphacickboxylate, an auna shi da rarraba su tsakanin hydrogen peroxide da kuma mafiumtuwa bayani.Smith, R. da Tanford, K. Hydrophobicity of Dogon-Al-AlkylcarinBoxylic acidtsari. National Makarantar Kimiyya. Kimiyya mu 70, 289 (1973).
Liu, J. et al. Da zarar-mako gano Semaglutide Analog of Glucagon-1 (GLP-1). J. magani. Sunadarai. 58, 7370-7380 (2015). Wannan aikin yana nuna a karo na farko da yiwuwar amfani da sau ɗaya a cikin sati mai kitse na mako-mako.
Øtergaard, S. et al. Tasirin mutum na jikin mutum aibci acid a kan karamin aiki da rabin rai. Kimiyya. Rahoton 11, 21179 (2021). Wannan labarin ya nuna mahimmancin yanayin mai mai, maimaitawa da kwanciyar hankali a cikin ci gaban rabin-rayuwa mai tsawo.
Ensenat-vaser, r. et al. Conetration na peptory peptides da aka lura ta kai tsaye ta amfani da cryrovalcence microvocalycence microvocalycence microvocycence microvocalycence microvocalycence microvocal. Iubb rai 54, 33-36 (2002).
Nelson, AR, BORLAND, L., Allland, NL & Sims, jigilar jigilar kaya a cikin kwayoyin ido. Nelson, AR, BORLAND, L., Allland, NL & Sims, jigilar jigilar kaya a cikin kwayoyin ido.Nelson Ar, Borland L, Mestrritton NL. Kuma Sims Se Peptide safari a cikin sel rayuwata ya dogara da myristmoyl. Nelson, Ar, Borland, L., Alllritton, NL & Sims, IT & Sims, IT 的 肽转运到活细胞 中 中. Nelson, Ar, Borland, L., Alllritton, NL & Sims, ce.Nelson, Ar, Borland, L., Albrirton, NL. Kuma Sims, Ke Sufurrin Peptistl-tushen peptides na rayuwa cikin sel mai rai.Biochemistry 46, 14771-14781 (2007).
Kabanov, Av, Levashov, av & Alakhov, vy Lipid Canjin sunadarai da kuma jigilar kayayyaki. Kabanov, Av, Levashov, av & Alakhov, vy Lipid Canjin sunadarai da kuma jigilar kayayyaki.Kabanov Av, Levashov Av, Alakhov V.Yu. Canjin Libid na sunadarai da kuma jigilar kayayyaki. Kabanov, Av, Alakhov, vy 的 脂质修饰及其膜转运. Kabanov, Av, Levashov, Av & Alakhov, vyKabanov Av, Levashov, Alakhov, gyaran lipid na sunadarai vy da kuma jigilar kayayyaki.Injiniyan Protein. Dec. Searl. 3, 39-42 (1989).
Gao, X., Mazière, AD, gemu, R. & Hannosh, rn fttach, rn ftt actide pepine-kulle peptide. Gao, X., Mazière, AD, gemu, R. & Hannosh, rn fttach, rn ftt actide pepine-kulle peptide.Gao, X., Mazier, Ad, Bark, R., Klumperman, J. da Hannoosh, RN mai kitsec, rn kloy acid actived ɗakin kwanciyar hankali tare da madauki na cystine tare da madauki mai kyau. Gao, X., Mazière, AD, gemu, ren, klumperman, J. & Hannosh, rn 的 的. Gao, X., Mazière, AD, gemu, R., Klumperman, J. & Hannosh, rn.Gao, X., Mazier, Ad, Bark, R., Klumperman, J. da Hannoosh, RN Veplic, RN FTOSMMICMIRS na Cystine Peptides na Cystine.Tabbas ne 24, 103220 (2021).
Baker, em et al. Canjin rabin-rai na tsinkaye na yy3-36 don shiga tsakani na kai tsaye. Moore. magani. 16, 3665-3677 (2019).
Mäde, V., Bellmann-Sickeert, K., Kaiser, A., MIler, J. & Beck-Sockinger, Ag Matsayi da Tsawon Kitse da Tsawon Kitse da kuma Tsawon Kitse da kuma Tsawon kitse da kuma Tsawon Kitse da kuma Tsawon Kitse na Polypeptiver na mutane pancroatic. Mäde, V., Bellmann-Sickeert, K., Kaiser, A., MIler, J. & Beck-Sockinger, Ag Matsayi da Tsawon Kitse da Tsawon Kitse da kuma Tsawon Kitse da kuma Tsawon kitse da kuma Tsawon Kitse da kuma Tsawon Kitse na Polypeptiver na mutane pancroatic.An yi, W., Bellmann-Sickeert, K., Kaiser, A., Mailer, J. da kuma Beck-Sockinger, AG Matsayi, AG Matsayi, AG Mäde, V., Bellmann-Sickeert, K., Kaiser, A., MIL ER, J. & Beck-Wellinger, ag 的 的 的. Mäde, V., Bellmann-Sickeert, K., Kaiser, A., MIL ER, J. & Beck-Weckinger, AGAn yi, W., Bellmann-Sickeert, K., Kaiser, A., Mailer, J. da kuma Beck-Screger, AG Matsayi, J. da Tsawon Kitse, AG Matsayi, AGHemanchem 9, 2463-2474 (2014).
Aleksopoulou, F. et al. A lebe na metabolite prrp31 wani dadewa ne dual gp10 kuma NPFF2 Mai karɓar agonist tare da tasirin asarar nauyi. Kimiyya. Rahoton 12, 1696 (2022). Wannan nazarin fasaha yana ba da ƙarin bambance-bambance tsakanin Mono- da dicid gefen sarƙoƙi.
Poulsen, K. et al. M ci gaban da barga agonists na y2 retopptor pyy33-36. magani. Tankalin ajiya. 38, 1369-1385 (2021).
Gafuwar-fruie, K. et al. Shaida da halayen a cikin vitro kuma a cikin tsarin vivo analungiyoyi na dadewa da kuma zaɓi Melanocrortin 4 mai ƙarfin gaske (MC4-R) Alpha-Mel). J. magani. Sunadarai. 55, 1969-1977 (2012).
Ramirez-Andersen, HS et al. Dogon aiki mai tsayi na mutum-ɗan adam an daure zuwa ga Album mara coilent. Bioconjugate. Sunadarai. 29, 3129-3143 (2018).
Madsen, K. et al. Tsarin tsari da kuma elongation na dogon-aiki Glucagon-kamar ptivaide-1 abubuwan sha: mahimmancin tsattsauran acid, palarity, da girma. J. magani. Sunadarai. 50, 6126-6132 (2007).
Wieczorek, B., Spetzler, JC, Kruue, T. & Linderoth, L. & Linderoth, L. & Linderoth, L. & Coinderoth, L. & Coinderoth, L. & Coinderoth, L. & Kofoed, J. sau biyu a iska mai kyau. Wieczorek, B., Spetzler, JC, Kruue, T. & Linderoth, L. & Linderoth, L. & Linderoth, L. & Coinderoth, L. & Coinderoth, L. & Coinderoth, L. & Kofoed, J. sau biyu a iska mai kyau. Wieczorek, B., Spetzler, JC, Kruue, T. & Linderoth, l. &вeroth, L. Wieczorek, B., Spetzler, JC, Kruue, T. & Linderoth, L. & Linderoth, L. & Barcelona, ​​J. Kofoed, J. Naman oybley, J. Naman acikin Acylated na Glp-1. Wieczorek, B., Spetzler, JC, Kruue, T. & Linderoth, L. & Barcelona, ​​J. 双酰化 Glp-1 衍生物. Wieczorek, B., Spetzler, JC, Kruue, T. & Linderoth, L. & Barcelona, ​​J. 双酰化 Glp-1 衍生物. Wieczorek, B., Spetzler, JC, Kruue, T. & Linderoth, l. & Linderoth, J. диацилированные ованыд. 1. Wieczorek, B., Spetzler, J., Linderoth, L. & Linderoth, L. & Barcelona, ​​L. & BarcelonaAmurka Patent WO2012 / 140117 (2012).
Young, P.CYU. Jira. Mai iko, da dadewa mai dadewa mai dadewa-1 an tsara don isar da canji na canji dangane da microstructure. tsari. Kungiyar Kwalejin Kimiyya ta kasa. Kimiyya. US 113, 4140-4145 (2016).
Sarauta, JE, Konradsen, Gonradsen, O., Eskerd, O., Wulff, Pharmacakynamics, da kuma binciken magunguna, da da yawa daga cikin α-msh analog a cikin lafiya kiba batutuwa. Sarauta, JE, Konradsen, Gonradsen, O., Eskerd, O., Wulff, Pharmacakynamics, da kuma binciken magunguna, da da yawa daga cikin α-msh analog a cikin lafiya kiba batutuwa.Sarauta, Je, Konradsen, G., Eskerd, O., Wolf, BS, Pharmacakyamics na dogon-msg assogn α-msg analogs a cikin lafiya compeight da kifiyya.I, Je, Konradsen, G., Eskerd, O., Wulf, BS & Hansen, BS & Hansen, BS & Hansen, BS & Hashen, BS & Hashen, BS & Hashen, BS & Hansen, BS & Hansen, BS & Hansen, BS & Hansen, BS & Hansen, BS & Hansen, BS & Hashen, BS动力学和药效学研究科目., Je, Konradsen, g药效学研究科目.Sarauta, Je, Konradsen, G., Eskerod, O., Wolf, BS da Hansen, Pasarin Pasul-MSG analogon a cikin lafiya-mSg. Kinetitiet da Pharmatoynamics.J. CLUS. Pharmatamynamics. 54, 394-4 (2014).
Lau, J., F., Kruue, T., Linderoth, L. & Thoggersen, H. & Thogersen, H. Lau, J., F., Kruue, T., Linderoth, L. & Thoggersen, H. & Thogersen, H.Lau, J., F., Kruue, T., linderoth, l. da yatsun kafa, H. New Glccagon analogues. Lau, J., F., Kruue, T., Linderoth, L. & Thoggersen, H. 新型胰高血糖素类似物. Lau, J., F., Kruue, T., Linderoth, L. & Thoggersen, H.Lau, J., F., Cruz, T., Linderoth, L. da kungiyoyin hamayya, H. New Glucagon Analogues.Amurka Patent Wo2011 / 117416 A1 (2011).
Ward, BP et al. Lipidation na peptides yana tsayar da tsarin don inganta aikin nazarin halittu. Moore. metabolism. 2, 468-479 (2013). Wannan aikin yana nuna rawar da kitse madauki ne a cikin yanke hukunci mai dorewa da kuma ɗaure makomar kida da kwayoyi.
Koskun T. et al. Ly3298176, wani sabon labari ne na wani labari da kuma murdurnist na 1 na 1 don maganin nau'in sukari na 2: daga gano Clinical na ra'ayi. Moore. metabolism. 18, 3-14 (2018). Wannan takarda tana gabatar da ƙirar na farkon mai-1 / gip Co-Agonist na mako-mako a cikin asibitin.
Kjelds, TB et al. Injin Injiniyan Injiniya na ICOODEC, na farko-sati-satima insulin analog analog a cikin mutane. J. magani. Sunadarai. 64, 8942-8950 (2021). Wannan takarda ta gabatar da ci gaban farko na mai da acid din da aka samo na insulin na mako daya.
Van Wetteroostein, SB et al. Neoglycolipids na dogon aiki peptides: Analungiyoyin da aka haɗa kai na Glucagonagon-Glucagon 1 tare da kaddarorin Albumin-Bind da kuma manyan kayan haɗin gwiwa. Moore. magani. 14, 193-205 (2017).
Zorzi, A. Middenendorp, sj, Wilbs, J., Deyle, K. & Hepteptueptipper da Aikace-aikacen ASINISESSISESSIDE. Zorzi, A. Middenendorp, sj, Wilbs, J., Deyle, K. & Hepteptueptipper da Aikace-aikacen ASINISESSISESSIDE.Zorzi, A. Middenendorp, sj, Wilbs, J., Willes, K. Acylated heptepepiter da kuma amfani da shi azaman lafazi yana samar da peptide mai aiki. Zorzi, A., MidDenendorp, sj, Wilbs, J., Deyle, K. & Hinis, C., 并作为标签提供长效肽. Zorzi, A., MidDenendorp, SJ, Wilbs, J., Deyle, K. & Hinis, C..Zorzi, A. Midderenp, sj, Wilbs, J., Wilbs, K. Acyliyan Heptpepties, S. Acylated heptopepties, s. oylated heptopepties, scylated heptopepites na samar da peptide.Nat. Sasa 8, 16092 (2017).